Back to Results
First PageMeta Content
Recombinant proteins / Pharmaceutical sciences / Biotechnology / Diabetes / Novo Nordisk / Center for Drug Evaluation and Research / New Drug Application / Insulin degludec / Insulin aspart / Food and Drug Administration / Biology / Peptide hormones


Microsoft Word - Post Meeting Agenda EMDAC[removed]doc
Add to Reading List

Open Document

File Size: 12,55 KB

Share Result on Facebook

Company

Novo Nordisk Incorporated. / SPONSOR PRESENTATIONS Novo Nordisk Inc. / PhD / /

Facility

Medicine University of Missouri / Meeting FDA White Oak Campus / White Oak Conference Center / University of Toronto Design / /

MedicalCondition

diabetes mellitus / /

Organization

Leadership Sinai Centre for Diabetes / Endocrinology Products / MDCM Diabetes Team Leader Division of Metabolism / office of Biostatistics / FDA / office of New Drugs / MDCM Diabetes Team Leader Division of Metabolism and Endocrinology Products / University of Toronto Design / office of Translational Sciences / Metabolic Drugs Advisory Committee / Medicine University / FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Endocrinologic / University of Missouri / Kansas City / /

Person

Alan Moses / Insulin Degludec Steve Marso / Paul T. Tran / Jean-Marc Guettier / Bernard Zinman / Safety Karim Anton Calis / Bo Li / Kenneth D. Burman / Anne Phillips / Eugenio Andraca-Carrera / Insulin Degludec Peter Kurtzhals / /

Position

Senior Vice President Diabetes Research Unit Novo Nordisk Clinical Development Program / General / Professor / Global Chief Medical Officer / Director / Consulting Cardiologist / Vice President Clinical Development / Medical and Regulatory Affairs / RPh Designated Federal Officer / Vice President Regulatory Affairs Novo Nordisk Defining / Professor of Medicine / Chairperson / /

ProvinceOrState

Missouri / /

SocialTag